News

RFK Jr.'s FDA officials overrode career staff to limit COVID shots
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
FDA vaccine official restricted COVID vaccine approvals against agency advice
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Top FDA vaccine official rejected broad use of Covid-19 shots, documents show
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Hosted on MSN7mon
FDA Approves Cobenfy for Adults With Schizophrenia - MSN
THURSDAY, Nov. 14, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of ...
ABC News9mon
FDA approves 1st new drug for schizophrenia in more than 30 years - ABC News
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...
Hosted on MSN9mon
FDA Approves New Kind of Drug for Schizophrenia
FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.
Managed Healthcare Executive2d
Expected FDA Approvals in the Second Half of 2025
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Fox News9mon
FDA approves new class of medication for schizophrenia patients | Fox News
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
NPR9mon
First new type of treatment for schizophrenia in decades : Shots - Health News - NPR
The Food and Drug Administration approved Cobenfy, a twice-a-day medication that is a new kind of treatment for schizophrenia in adults. Steve Belkowitz/Bristol Myers Squibb hide caption ...
Healio9mon
FDA approves first new class of schizophrenia treatment in more than 30 years - Healio
The FDA has approved Cobenfy, formerly known as KarXT, a muscarinic acetylcholine receptor agonist for the treatment of schizophrenia in adults. Cobenfy (xanomeline-trospium, Bristol Myers Squibb ...
Pharm Exec9mon
FDA Approves Bristol Myers Squibb’s Cobenfy for Schizophrenia
By leveraging a novel pathway, Cobenfy offers a new option to manage this challenging condition.” References. 1. U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline ...
WBAL9mon
FDA approves first new drug for schizophrenia in more than 30 years | WBAL Baltimore News - WBAL NewsRadio 1090/FM 101.5
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...